HAEMONETICS CORPORATION (HAE) Operating cash flow 2017–2026
HAEMONETICS CORPORATION (HAE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$293.2MFY2026 · since FY2017: $159.7M → $293.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $293.2M | +61.4% |
| FY2025 | $181.7M | -0.0% |
| FY2024 | $181.8M | -33.4% |
| FY2023 | $273.1M | +58.5% |
| FY2022 | $172.3M | +58.3% |
| FY2021 | $108.8M | -31.2% |
| FY2020 | $158.2M | -0.7% |
| FY2019 | $159.3M | -27.7% |
| FY2018 | $220.3M | +37.9% |
| FY2017 | $159.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice